Momenta Shelves Adalimumab But Persists With Aflibercept

 
• By Aidan Fry
  
old books on the shelf - Image
Commercial considerations have led Momenta to shelve active development on its M923 adalimumab candidate • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products